|
|
|
|
Congratulations to two amazing physicians who treat Neuroendocrine Tumor patients upon being selected for the 2020 40 Under 40 in Cancer: Arturo Loaiza-Bonilla, MD, Gastrointestinal Program Director and Medical Director of Clinical Research at Cancer Treatment Centers of America in Philadelphia, where he also serves as the hospital’s Chief of Medical Oncology and Medical Director of Research, and Namrata Vijayvergia, MD, Assistant Chief of Gastrointestinal Medical Oncology at Fox Chase Cancer Center in Philadelphia and Medical Director, Medical Oncology for Fox Chase Cancer Center Partners. 40 Under 40 in Cancer is an awards initiative to identify and recognize the contributions being made across the field of cancer by rising stars and emerging leaders under the age of 40 years. Finalists and awardees will be selected by a panel of reviewers from across diverse roles in oncology.
| |
Newly published articles of interest to the NET community include:
| |
Register now for one or more of three upcoming NET patient virtual conferences:
| |
Mark Lewis, MD, a gastrointestinal oncologist at Intermountain Healthcare in Utah who self-diagnosed his multiple endocrine neoplasia type 1 (MEN1), is a featured guest on the podcast Your Stories: Conquering Cancer, presented by the ASCO Foundation. The series showcases conversations between people within the cancer community – including doctors, researchers, patients, caregivers – who candidly share their experiences to connect with others who have been impacted by cancer. Listen to Dr. Lewis’ story here. Dr. Lewis is also a host for Season 4 of the podcast series.
| |
Did you know that the International Neuroendocrine Tumor Alliance (INCA), has free, NET info packets in 10 languages? Click here to select your language and download the factsheets.
| |
Advanced Accelerator Applications (AAA) has expanded its financial assistance programs for NET patients who are treated with Lutathera. For more information about AAA PatientCONNECT, visit www.aaapatientconnect.com and click on Patient Access Support or call 1-844-638-7222.
| |
Read a wonderful tribute to the late Mitch Berger upon the 40th anniversary of Fordham University’s newspaper, The Observer, for which he was a founding editor-in-chief. A leader in the neuroendocrine tumor community, Mitch will forever be in our thoughts and hearts.
| |
|
|
|
The Carcinoid Cancer Foundation's educational, awareness and advocacy activities are made possible by your contributions. These crucial activities lead toward early detection, improving the quality of life for cancer survivors, and ultimately to a cure. The Carcinoid Cancer Foundation is a 501(c)(3) nonprofit organization. All contributions to the Carcinoid Cancer Foundation are tax-deductible to the extent allowed by law. Thank you for your support.
|
|
Carcinoid Cancer Foundation
118 North Bedford Road, Suite 100
Mt. Kisco, NY 10549
888.722.3132
carcinoid@carcinoid.org
|
|
|
|